Cargando…

GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival

BACKGROUND: Various parameters have been considered for predicting survival in pancreatic ductal adenocarcinoma. Information about western population is missing. The aim of this study is to assess the association between Glucose transporter type 1 (GLUT-1) expression and prognosis for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Achalandabaso Boira, Mar, Di Martino, Marcello, Gordillo, Carlos, Adrados, Magdalena, Martín-Pérez, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510075/ https://www.ncbi.nlm.nih.gov/pubmed/32967636 http://dx.doi.org/10.1186/s12885-020-07409-9

Ejemplares similares

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
por: Sun, Hong-Wei, et al.
Publicado: (2016)

Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2022)

The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers
por: Chakladar, Jaideep, et al.
Publicado: (2020)

Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Knipper, Karl, et al.
Publicado: (2023)

Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth
por: Contat, Caroline, et al.
Publicado: (2020)

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Salmiheimo, Aino, et al.
Publicado: (2016)

Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival
por: Botrus, Gehan, et al.
Publicado: (2022)

Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation()
por: Yang, Hai-Jing, et al.
Publicado: (2016)

Overexpression of carbohydrate sulfotransferase 15 in pancreatic cancer stroma is associated with worse prognosis
por: Matsuda, Yoko, et al.
Publicado: (2019)

Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma
por: Wang, Jue, et al.
Publicado: (2016)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma
por: Zhou, Jiayu, et al.
Publicado: (2018)

Fructose fuels lung adenocarcinoma through GLUT5
por: Weng, Yuanyuan, et al.
Publicado: (2018)

Upregulated expression of NOP2 predicts worse prognosis of gastric adenocarcinoma by promoting tumor growth
por: Feng, Jingyu, et al.
Publicado: (2022)

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma
por: Ye, Chenyang, et al.
Publicado: (2022)

CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis
por: Yu, Senlong, et al.
Publicado: (2023)

Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?
por: De Simoni, Ottavia, et al.
Publicado: (2023)

Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma
por: Sergeant, Gregory, et al.
Publicado: (2011)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma [Corrigendum]
Publicado: (2019)

High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma
por: Knipper, Karl, et al.
Publicado: (2023)

A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1
por: Libby, Catherine J, et al.
Publicado: (2021)

Pancreatic Adenocarcinoma in Patients with Type 2 Diabetes: Prognosis and Survival
por: Turjoman, Meshari A, et al.
Publicado: (2020)

GLUT10 is a novel immune regulator involved in lung cancer immune cell infiltration and predicts worse survival when transcriptionally downregulated
por: Jian, Lijuan, et al.
Publicado: (2023)

Near infrared indocyanine green fluorescent cholangiography versus intraoperative cholangiography to improve safety in laparoscopic cholecystectomy for gallstone disease—a systematic review protocol
por: Pavel, Mihai-Calin, et al.
Publicado: (2022)

Clinical Predictors of Resectability of Pancreatic Adenocarcinoma
por: Almadi, Majid A., et al.
Publicado: (2013)

GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle
por: Aerni-Flessner, Lauren, et al.
Publicado: (2012)

Assessment of the association of OCT3/4 with GLUT1 and CD105 in oral squamous cell carcinoma using dual immunohistochemistry
por: Derakhshan, Samira, et al.
Publicado: (2022)

CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma
por: Zhang, Sen, et al.
Publicado: (2022)

OPN and αvβ3 Expression are Predictors of Disease Severity and Worse Prognosis in Hepatocellular Carcinoma
por: Jin, Yi, et al.
Publicado: (2014)

Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
por: Krzeslak, Anna, et al.
Publicado: (2012)

Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
por: Luu, Tuan Trong
Publicado: (2021)

Expression of the glucose transporters GLUT1, GLUT3, GLUT4 and GLUT12 in human cancer cells
por: Barron, Carly, et al.
Publicado: (2012)

GLUT1 Regulates the Tumor Immune Microenvironment and Promotes Tumor Metastasis in Pancreatic Adenocarcinoma via ncRNA-mediated Network
por: Li, Fengjiao, et al.
Publicado: (2022)

Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
por: MacCurtain, Benjamin M., et al.
Publicado: (2021)

Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma
por: Wang, Bingzhi, et al.
Publicado: (2021)

Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis—a case control study
por: Claire, Decoster, et al.
Publicado: (2016)

YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer
por: Bencivenga, Maria, et al.
Publicado: (2023)

ERG Immunohistochemistry and Clinicopathologic Characteristics in Korean Prostate Adenocarcinoma Patients
por: Suh, Ja Hee, et al.
Publicado: (2012)

(Pro)renin Receptor Expression Increases throughout the Colorectal Adenoma—Adenocarcinoma Sequence and It Is Associated with Worse Colorectal Cancer Prognosis
por: Beitia, Maider, et al.
Publicado: (2019)

Intraoperative Transfusion is Independently Associated with a Worse Prognosis in Resected Pancreatic Cancer—A Retrospective Cohort Analysis
por: Kim, Si Youn, et al.
Publicado: (2020)

Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis
por: Dong, Shu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k9uiiug752puuhdh5dojprneag